- Home
- ACIU vs ONEW Comparison
ACIU vs ONEW Comparison
Compare ACIU & ONEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- ONEW
- Stock Information
- Founded
- ACIU 2003
- ONEW 2014
- Country
- ACIU Switzerland
- ONEW United States
- Employees
- ACIU N/A
- ONEW N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- ONEW Auto & Home Supply Stores
- Sector
- ACIU Health Care
- ONEW Consumer Discretionary
- Exchange
- ACIU Nasdaq
- ONEW Nasdaq
- Market Cap
- ACIU 332.4M
- ONEW 318.6M
- IPO Year
- ACIU 2016
- ONEW 2020
- Fundamental
- Price
- ACIU $2.64
- ONEW $18.26
- Analyst Decision
- ACIU Strong Buy
- ONEW Buy
- Analyst Count
- ACIU 2
- ONEW 5
- Target Price
- ACIU $12.00
- ONEW $29.00
- AVG Volume (30 Days)
- ACIU 132.5K
- ONEW 109.8K
- Earning Date
- ACIU 11-05-2024
- ONEW 01-30-2025
- Dividend Yield
- ACIU N/A
- ONEW N/A
- EPS Growth
- ACIU N/A
- ONEW N/A
- EPS
- ACIU N/A
- ONEW N/A
- Revenue
- ACIU $48,505,404.00
- ONEW $1,772,630,000.00
- Revenue This Year
- ACIU $85.33
- ONEW $3.74
- Revenue Next Year
- ACIU $80.69
- ONEW $5.06
- P/E Ratio
- ACIU N/A
- ONEW N/A
- Revenue Growth
- ACIU 4097200.00
- ONEW N/A
- 52 Week Low
- ACIU $2.25
- ONEW $17.62
- 52 Week High
- ACIU $5.14
- ONEW $35.86
- Technical
- Relative Strength Index (RSI)
- ACIU 27.22
- ONEW 34.08
- Support Level
- ACIU $2.63
- ONEW $17.62
- Resistance Level
- ACIU $3.07
- ONEW $18.52
- Average True Range (ATR)
- ACIU 0.15
- ONEW 1.01
- MACD
- ACIU -0.04
- ONEW -0.28
- Stochastic Oscillator
- ACIU 8.96
- ONEW 6.60
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segment- Dealerships and Distribution. Its dealer groups are located throughout the Southeast, Gulf Coast, Mid-Atlantic, and Northeast. The company's revenue profile is comprised of new boat sales, pre-owned boat sales, finance and insurance products, repair and maintenance services, and parts and accessories. Majority of revenue is generated from sale of new boats.